Shu S, Lin CY, He HH, et al. Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Nature. 2016;529(7586):413-7. doi:10.1038/nature16508
Moses AM, Chiang DY, Kellis M, Lander ES, Eisen MB. Position specific variation in the rate of evolution in transcription factor binding sites. BMC Evol Biol. 2003;3:19. doi:10.1186/1471-2148-3-19
Buskirk AR, Kehayova PD, Landrigan A, Liu DR. In vivo evolution of an RNA-based transcriptional activator. Chem Biol. 2003;10(6):533-40.